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Abstract
Unrepaired or misrepaired DNA damage has been implicated as a causal factor in cancer and aging. Xpd
TTD mice, harboring
defects in nucleotide excision repair and transcription due to a mutation in the Xpd gene (R722W), display severe symptoms
of premature aging but have a reduced incidence of cancer. To gain further insight into the molecular basis of the mutant-
specific manifestation of age-related phenotypes, we used comparative microarray analysis of young and old female livers
to discover gene expression signatures distinguishing Xpd
TTD mice from their age-matched wild type controls. We found a
transcription signature of increased apoptosis in the Xpd
TTD mice, which was confirmed by in situ immunohistochemical
analysis and found to be accompanied by increased proliferation. However, apoptosis rate exceeded the rate of
proliferation, resulting in homeostatic imbalance. Interestingly, a metabolic response signature was observed involving
decreased energy metabolism and reduced IGF-1 signaling, a major modulator of life span. We conclude that while the
increased apoptotic response to endogenous DNA damage contributes to the accelerated aging phenotypes and the
reduced cancer incidence observed in the Xpd
TTD mice, the signature of reduced energy metabolism is likely to reflect a
compensatory adjustment to limit the increased genotoxic stress in these mutants. These results support a general model
for premature aging in DNA repair deficient mice based on cellular responses to DNA damage that impair normal tissue
homeostasis.
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Introduction
Aging is a highly complex process characterized by functional
decline, reduced reproductive capacity and an increase in the
likelihood of disease and death. One experimental approach for
studying the mechanisms of aging is provided by natural or
engineered genetic alterations that accelerate the normal aging
process [1]. Human and mouse models of accelerated aging
frequently involve heritable defects in genome maintenance
mechanisms, implicating spontaneous genotoxic stress as an
important causal factor in age-related deterioration and death [2].
An importance source of endogenous genotoxic stress, i.e. reactive
oxygen species (ROS), have been proposed to ultimately drive most
processes of age-related cellular degeneration and death [3].
Genetic defects in nucleotide excision repair (NER) are
associated with premature aging in both humans and mice [4].
NER removes helix-distorting types of DNA lesions, such as UV-
induced pyrimidine dimers, but has also been demonstrated to
repair oxidative damage [5]. Global genome NER (GG-NER)
operates genome-wide and is important for preventing mutations.
Transcription-coupled NER (TC-NER), on the other hand,
eliminates lesions that block the transcription machinery, thus
helping to repair those genes that are currently active. Mice
completely devoid of GG-NER, as in Xpa knock out mice, are
similar to human xeroderma pigmentosum patients and show
increased susceptibility to UV-induced skin cancer [6], but no
obvious signs of premature aging. However, two other NER-
related disorders, Trichothiodystrophy (TTD) and Cockayne
Syndrome (CS), display prominent symptoms of accelerated aging,
which is reflected by the corresponding mouse models [7,8].
The XPD gene encodes the 59 to 39 DNA helicase subunit of
basal transcription factor TFIIH, which is involved in both GG-
and TCR-NER [5]. Complete inactivation of the XPD helicase is
not viable in the mouse or in cells. Mice carrying a trichothio-
dystrophy (TTD) type of mutation (R722W) in the Xpd gene
revealed a striking correspondence with the complex pleiotropic
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reduction of hair-specific cysteine-rich matrix proteins resulting in
brittle hair, but also growth delay, reduced fertility and life span,
loss of subcutaneous fat, and UV sensitivity. At the level of DNA
repair the Xpd
TTD mutation causes a partial defect in both GG-
NER and TC-NER. In addition, the Xpd
TTD causes a defect in
general transcription resulting in 60–70% reduction of basal
transcription in vitro [9].
The phenotype of Xpd
TTD mice not only mimics that of the
human disease, TTD, but is also reminiscent of segmental
premature aging [10,11]. Apart from reduced body and organ
weight, age-related pathology was found to be most prominent in
liver, kidney, bones, and lymphoid tissues [11]. These include
lipofuscin accumulation, intranuclear inclusions, and hepatocellu-
lar atrophy in the liver; karyomegaly, tubular dilatation, and
hyaline glomerulopathy in the kidney; lymphoid depletion in the
spleen and thymus; aortic sarcopenia; and osteoporosis femur.
Unexpectedly, these premature aging features are accompanied by
phenotypes that are normally observed after caloric restriction
(CR), the only intervention known to extend life span and delay
many aspects of aging in rodents [12]. These include a lower
incidence and/or severity of cancer, cataract, ulcerative derma-
titis, hypodermal fat, nerve demyelination, thyroid follicular
distension, and inflammation in various organs [11]. It is thus
an open question as to how the mechanisms that lead to
accelerated aging in the Xpd
TTD coexist with the pathways that
extend life span and delay age-associated pathology in CR mice.
In this study, we investigated the impact of the Xpd
TTD
mutation on the physiology of the liver, using global microarray
gene expression analysis. Liver was selected for this analysis
because as the central metabolic organ of the body it is a major
target of oxidative DNA damage, a postulated cause of aging, and
suffers from some prominent aging-related pathology [11]. The
results indicate apoptosis-related genes as a prominent gene
expression signature associated with the Xpd
TTD mutation. This
was confirmed by the direct demonstration of increased apoptosis,
which was accompanied by increased proliferation. However,
apoptosis rate exceeded the rate of proliferation, resulting in
homeostatic imbalance. Somewhat surprisingly, this homeostatic
imbalance of apoptosis and cell renewal in the liver was found to
be associated with gene expression profiles pointing towards a
metabolic response involving decreased energy metabolism and
reduced IGF-1 signaling, normally associated with delayed aging
and increased life span. The data presented here support the
hypothesis that the homeostatic imbalance between cell loss and
cell renewal underlies premature aging in the Xpd
TTD mice
through a complex interplay between cellular responses and
compensatory metabolic adjustments to increased genotoxic stress.
Results
Expression profiling of Xpd
TTD mutant liver
To gain insight into the molecular basis of the mutant-specific
manifestation of age-related phenotypes, we used comparative
microarray analysis of young (3 months) and old (20 months)
female livers to discover gene expression signatures distinguishing
Xpd
TTD mice from their age-matched wild type controls, using
custom long-oligonucleotide (70-mer) DNA microarrays contain-
ing 16,463 genes. We chose liver because it is a central metabolic
organ of the body and plays a key role in whole-body energy
metabolism through the integrated control of hepatic glucose and
lipid metabolism. We identified a total of 417 genes (182 up-
regulated, 235 down-regulated) at young age and 656 genes (312
up-regulated, 344 down-regulated) at old age, which were
significantly different between the mutant and wild type. The
complete lists of these genes are presented in Tables S1 and S2.
We selected genes with a diverse range of fold change (from 1.3 to
7) for our validation studies using qRT-PCR. Of the 31 genes
tested, all genes produced gene expression patterns consistent with
the microarray data (Figure S1). The microarray data clearly
underestimated the gene expression fold changes when compared
with the qRT-PCR analysis, as almost all of the genes show more
dramatic fold changes in gene expression according to the qRT-
PCR than with the microarray data (Figure S1). Despite the
underestimation of fold change, the strong correlation between
results from microarray and qRT-PCR indicate that the data
obtained from the microarray analysis are highly reliable.
Gene Ontology (GO) annotation using GoMiner software
identified functional categories that were significantly over-repre-
sented in the Xpd
TTD livers (see Tables S3 and S4 for the complete
list). At young age, major GO categories included cell death,
defense/immune response, oxidoreductase activity, and lipid
metabolism (Figure 1A). The behavior of genes in some of these
major categories shows a significant unidirectional tendency to be
either mostly upregulated or mostly down-regulated (see Supple-
mentary Table S3). For example, at young age, among the genes in
the GO category of cell death, significant over-representations of up-
regulated genes were prominent for the categories of apoptosis
(p=0.02) and induction of apoptosis (p=0.04). Similarly, over-
representation of genes involved in defense response (p=0.04) was
mostlyduetosignificantover-representationofup-regulatedgenesin
the sub-category of immune response (p=0.03) rather than over-
representation of down-regulated genes in this sub-category
(p=0.34). Especially over-representation of up-regulated genes in
the sub-categories of acute-phase response (p,0.0001) and humoral
immune response (p,0.001) was highly significant. Likewise, genes
involved in the category of oxidoreductase activity were over-
represented by significant down-regulation of genes in the sub-
categories of monooxygenase activity (p=0.01) and transferase
activity (p=0.02). Moreover, genes involved in the category of lipid
metabolism were over-represented by significant down-regulation of
genes in the sub-categories of fatty acid metabolism (p,0.001) and
lipid/steroid biosynthesis (p,0.001).
At old age, four major categories of genes were found to be
significantly overrepresented (p,0.05): defense/immune response,
oxidoreductase activity, generation of precursor metabolites and
energy, and lipid metabolism (Figure 1B). Old Xpd
TTD livers
showed trends very similar to their young counterparts, except that
the genes under the category of defense/immune response were
significantly down-regulated (p,0.001) and up-regulation of genes
in this same category was not significant (p.0.9). Down-regulation
of genes involved in the sub-categories of antigen presentation
(p,0.001) and humoral immune response (p,0.001) was highly
significant, the opposite direction as in their young-counterparts.
Although not significantly over-represented as a category in GO
analysis (p=0.52), a total of 27 genes in the category of apoptosis
were differentially regulated at old age in the liver of Xpd
TTD mice
compared to control mice (Table S5).
Complex phenotypes are controlled by the dynamic actions of
thousands of genes. While GO analysis offers tremendous value, it
also has limitations, such as the lack of direct association with
pathways. Global organization of genes into pathways and their
interactions can be identified through construction of genomic
networks [13]. To analyze functional pathways that are co-
coordinately regulated and that may contribute to premature
aging phenotypes associated with the Xpd
TTD mutation, we
further analyzed microarray expression data using PathwayAssist
(see Materials and Methods). Several functionally linked clusters of
Premature Aging
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TTD liver in comparison to
age-matched wild type controls were identified. Figure 1C shows
an example of the comparison between the Xpd
TTD mutant and
wild type controls at old age. We observed clustering of genes into
four integrated modules: lipid metabolism, defense/immune
response, electron transport and cell signaling/cell proliferation.
In keeping with the GO analysis, of these clusters lipid metabolism
was mostly down-regulated in the Xpd
TTD mutant liver.
Interestingly, the pathway analysis pointed towards PPARa as a
major regulator responsible for the coordinated down-regulation
of genes involved in lipid metabolism in the Xpd
TTD mutant liver
(Figure 1C). Importantly the pathway analysis also revealed the
signature of IGF1 resistance in the liver, namely up-regulation of
IGF1R and IGFBP [14], in the cell signaling/cell proliferation
cluster. At young age, lipid metabolism module was prominent,
whereas the functional clusters of other modules were not
immediately apparent by the pathway analysis (results not shown).
Thus, we identified a series of interacting genes, which
constitute differential regulation of potentially important signaling
pathways, as characteristic of the Xpd
TTD mutant liver. Of these
pathways, since up-regulation of apoptosis has been considered as
a causal factor in premature aging phenotypes [15], we directly
quantified the frequency of apoptotic cells in Xpd
TTD mutant liver
(see below). In addition, we further explored the down-regulation
of IGF1 signals, which could possibly explain the observed
decrease in lipid and energy metabolism consistently found in
Xpd
TTD mutant liver. Of note, down-regulation of IGF1 signaling
is linked to extension but not shortening of life span across multiple
species [16] and could possibly explain the CR symptoms that are
also part of the Xpd
TTD phenotypes [11].
Apoptosis and cell renewal in the liver of Xpd
TTD mutant
mice
Apoptosis, a major cellular response to DNA damage, is known
to be regulated at the post-transcriptional level through activation
of protein cascades, especially the core apoptotic machinery [17].
Surprisingly, however, GO analysis highlighted the functional
categories of genes related to apoptosis as significantly over-
represented in young but not in old Xpd
TTD mutants compared to
the wild type controls. These include upregulation of genes under
the category of apoptosis (TNFRSF6 (FAS), TNFRSF3 (LTBR),
TRAF1, F2, EIF5A. CLU, C9, CSTB, CEBPB, DSIP1, APOE,
TDE1, IL18) and down-regulation of genes under the subcategory
of anti-apoptosis (PRLR, TGFB1, VEGFA) suggesting that the
induction of apoptosis may occur through the expression of pro-
apoptotic genes and the down-regulation of anti-apoptotic genes in
the liver of Xpd
TTD mutants at young age (Table S5). The GO
analysis pointed out the possible involvement of the death receptor
Figure 1. Biological characterization of the Xpd
TTD global gene expression profile in liver. (A) Selected Gene Ontology categories of
significant changes in the Xpd
TTD mutant mice compared to the wild type at 3 months (young). Only the GO categories that were significantly
overrepresented (p,0.05) relative to overall microarray are indicated together with the number of genes significantly altered in each category (X-
axis). The Red and Green bar indicate numbers of up- and down-regulated genes, respectively, in each category. Significant over-representation of
up- or down-regulated genes in each category is indicated with an asterisk. *,0.01. ** ,0.001. (B) Selected Gene Ontology categories of significant
changes in the Xpd
TTD mutant mice compared to the wild type at 20 months (old). (C) Functional pathways that are altered in the Xpd
TTD mice
compared to the wild type animals. Green symbols represent genes that are downregulated in Xpd
TTD compared to wild type and red symbols
represent genes that are upregulated in Xpd
TTD compared to the wild type mice. Clusters of genes in lipid metabolism (lower left), defense/immune
response (upper left), and electron transport (lower right) were mostly down-regulated, whereas genes in cell signaling and cell proliferation (upper
right) were mostly upregulated.
doi:10.1371/journal.pone.0002346.g001
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TTD liver. The death
receptor pathway, or the extrinsic pathway, is mediated by the cell
surface TNF-a receptor super-family (Tnfrsf) members, including
Fas and TNF-a receptor, and is the major pathway leading to
hepatocyte apoptosis [18] [19].
To examine if the GO-predicted increase in apoptosis actually
occurred, we directly assessed the level of apoptosis using tissue
arrays constructed from liver of young and old Xpd
TTD mutant
and control mice. Apoptotic cell death was examined using
apoptosis-induced DNA fragmentation by in situ labeling (TU-
NEL). In the livers of young control mice, very few apoptotic cells
were observed and the number of apoptotic cells increased only
slightly with age (Figure 2A and 2B). However, a substantial
number of cells bearing fragmented DNA were detected in the
liver of mutant mice at young age and this number increased with
age (Figure 2A and 2B). The increase in apoptosis in liver of the
Xpd
TTD mutant was confirmed by immunohistochemistry using
antibody specific for activated Caspase-3 (Figure 2A).
Activation of p53 is a major cellular response to DNA damage
[20] [21]. It promotes diverse cellular processes, such as DNA
repair and cell cycle arrest, allowing cells to recover from the
damage, or initiate permanent growth arrest (senescence) or
apoptosis if the damage to DNA is too severe to repair. Under
normal conditions, p53 is held in a latent inactive state but
undergoes a significant increase in protein stability after DNA
damage [22]. To investigate if the observed increase in apoptosis
in the Xpd
TTD mutant mice involves activation of p53, we
examined the expression of p53 by immunohistochemistry in the
liver using the same tissue arrays. While p53 immunoreactivity was
absent in the liver of control mice, high levels of nuclear staining of
p53 in hepatocytes were evident in the liver of mutant mice
(Figure 2A). While not quantified, caspase-3 and p53 staining
followed the same trend as TUNEL assay, i.e. increase with age
and in the mutant compared to wild type controls (Figure 2B, data
not shown). In keeping with these results, our microarray data
indicated an up-regulation of GADD45G, a major p53 target gene
and strong potentiator of apoptosis [23], in the Xpd
TTD liver at
old age (Figure 1C and Table S2). Combined with the pattern of
gene expression related to apoptosis described above, these results
demonstrate that there is a strong induction of apoptotic cell death
in the liver of mutant mice at both young and old age.
Reasoning that the rate of cell loss must be balanced by the rate
of cell renewal to avoid organ failure and ultimately death, at a
much earlier age than actually observed, we subsequently
evaluated cell proliferative responses in the liver of these mice
using in situ Ki-67 immunostaining. We detected a significant
increase in Ki-67 positive hepatocytes at 6 month of age in the
Xpd
TTD compared to the wild type liver, with substantially lower
differences at 12 and 18 months (Figure 2C and 2D). However,
the number of Ki-67 positive cells was much lower compared to
the TUNEL positive cells even at young age (Figure 2A and 2B),
suggesting that there is a homeostatic imbalance between cell loss
and cell renewal in the liver of Xpd
TTD mice with an eventual shift
towards net cell loss at older age.
Attenuation of IGF-1 signaling in the liver of Xpd
TTD
mutant mice
Interestingly, IGF1R was up-regulated in the Xpd
TTD mutant
liver compared to that of the wild type controls, which suggests
compensatory up-regulation in response to reduced IGF-1 action
Figure 2. Homeostatic imbalance between cell loss and cell renewal in the Liver of Xpd
TTD Mice. (A) Liver sections from the control mice and
Xpd
TTD mutantmiceshowinginsitulabelingofnuclear DNA fragmentation(TUNEL, X200),staining ofactive formofCaspase-3(X400)andp53 expression
(X200). Data show representative pictures of similar results obtained from three independent experiments. (B) The numbers of apoptotic cells by TUNEL
staining. Each determination point is the average of three animals. Asterisks indicate statistical significance assessed by Wilcoxon Mann-Whitneyt e s t
(**P=0.00006,*P=0.002). Bars indicate the standard deviations. (C) Liver sections from the control mice and Xpd
TTD mutant mice showing in situstaining
of Ki-67 (X200). (D) The numbers of Ki-67 positive cells by Ki-67 staining. Each determination point is the average of four animals. Asterisks indicate
statistical significance assessed by Wilcoxon Mann-Whitney test (**P=0.000003, *P=0.088). Bars indicate the standard deviations.
doi:10.1371/journal.pone.0002346.g002
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of delayed rather than accelerated aging [16]. To assess the effects
of the Xpd
TTD on the IGF axis we measured the serum levels of
IGF-1, IGFBP-1 and IGFBP-3. IGF-1 levels were lower in the
mutant mice (P,0.01) and this effect was more pronounced at old
age (Figure 3A). As expected from the gene expression data
(Figure 1C) IGFBP-3 levels were also significantly (20–30%,
p,0.01) lower in Xpd
TTD mice compared to controls (Figure 3B),
while IGFBP-1 levels were elevated 2- to 6-fold in Xpd
TTD mice at
both young and old age (p,0.05) compared to age-matched
controls, with a much steeper age-related increase in IGFBP-1
levels in the mutants (Figure 3C). Up-regulation of IGFBP1 in the
mutant liver was also confirmed at both mRNA (Figure S1) and
protein (Figure 3D) levels. The weight of these mice inversely
correlated with the IGFBP-1 levels (r=0.58, p,0.01), and directly
correlated with the IGF-1/IGFBP-3 ratio (r=0.43, p,0.0002)
with 30% reduction in Xpd
TTD mice compared to wild type at old
age (p,0.01). Xpd
TTD mice at old age were 30% smaller than
controls (data not shown), compatible with inhibition of the
growth-promoting IGF system. Taken together, the serum profiles
typically accompany inhibition of the growth-promoting IGF-1
system in mice [14,16] and confirmed the reduced signaling of the
IGF-1 axis in the Xpd
TTD mice at both young and old age.
Major metabolic changes in the liver of Xpd
TTD mutant mice
We observed a dramatic down-regulation of genes related to the
functional category of lipid metabolism at both young and old age
in the liver of Xpd
TTD mice as compared to the wild type controls
(Figure 1 and Table S5). Notably, genes involved in fatty acid
metabolism, which include both biosynthesis and catabolism, are
significantly down-regulated at both 3 months of age (AACS,
ABCD2, ACAA1, ELOVL5, FABP1, FABP3, FASN, FDFT1) and
20 months of age (ACAA1, ACAA2, ADH4, DCI, DBI, DHRS3,
ELOVL5, FABP1, FADS1, FASN, HADHSC, HSD17B4, PCCB,
PECR, PPARA, SCP2),whereas only one (RARRES2) and 6 genes
(AASDHPPT, FADS3, MYLCD, PRKAG1, PPARGC1A, RBP1)
were found to be up-regulated at 3 months and 20 months,
respectively. Moreover, the GO category of steroid (cholesterol)
biosynthesis comprised not a single up-regulated gene, but all
down-regulated genes, at both 3 months (ACYP51, CYP51,
DHCR7, FDFT1, FDPS, HMGCS2, NSDHL, PRLR, SC5D,
SQLE, STARD4, TM7SF2) and 20 months (AKR1C20,
HSD3B1, HSD3B3, DBI, FDPS, HMGCS2, HSD17B12,
HSD17B4, HSD3B1, HSD3B3, PRLR, OPRS1, SC5D, SCP2,
SEC14L2, SQLE, TM7SF2) of age. These transcriptional changes
suggest that metabolic pathways central to fatty acid and
cholesterol homeostasis are significantly altered in Xpd
TTD liver,
both at young and old age. Consistently, we observed down-
regulation of genes involved in the TCA cycle (IDH1, SULCG2)
and oxidative phosphorylation (ATPJ5, ATP6V0C, COX5B,
NDUFC1, NDUFS5, UQCRB). The concerted down-regulation
of genes involved in fatty acid metabolism and oxidative
phosphorylation may have significant impact on mitochondrial
function or ROS production. Interestingly, some of the most
significant alterations in this group of genes were found to involve
genes of complex I of the respiratory chain (NDUFA10, NDUFA6,
NDUFB10, NDUFC1, NDUFS5). Complex I may be one of the
major physiologically and pathologically relevant ROS-generating
sites in mitochondria [24]. We also observed down-regulation of
other components of the electron transport chain, such as
cytochrome C reductase in complex III (UQCR, UQCRB) and
ATP synthase in complex V (ATP5J, ARP5J2).
Figure 3. Down-regulation of IGF-1 signaling in Xpd
TTD mutants. (A) The serum levels of murine IGF-1 from 6 Xpd
TTD mutants and 6 controls
at young (3 months) and old (20 months) age. Bars indicate the mean standard error. Asterisks indicate statistical significance assessed by ANOVA.
(*P,0.05). (B) The serum levels of murine IGFBP-3 from 6 Xpd
TTD mutants and 6 controls at young (3 months) and old (20 months) age. Bars indicate
the mean standard error. Asterisks indicate statistical significance assessed by ANOVA. (*P,0.05). (C) The serum levels of murine IGFBP1 from 6
Xpd
TTD mutants and 6 controls at young (3 months) and old (20 months) age. Bars indicate the mean standard error. Asterisks indicate statistical
significance assessed by ANOVA. (*P,0.05). (D) Hepatic over-expression of IGFBP1 assessed by immunohistochemistry.
doi:10.1371/journal.pone.0002346.g003
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The transcriptome is now generally considered an important
molecular phenotype to be analyzed and linked to clinico-
pathophysiological phenotypes, as an aid in the identification of
new pathways and the generation of new hypotheses. In this
present study, we used global gene expression profiling to gain
further insight into the molecular mechanism leading to the
segmental premature aging phenotype of the Xpd
TTD mutant
mice harboring defects in NER and general transcription.
Homeostatic imbalance in the liver of Xpd
TTD mice
Gene Ontology analysis indicated that the majority of the
functional categories that are significantly over-represented in the
Xpd
TTD mice are due to significant down-regulation of genes in
these categories rather than up-regulation, except for a few major
categories (Figure 1, Supplementary Table S3 and S4). Apoptosis
was among a few functional categories that were over-represented,
due to the up-regulation of genes in the category at young age.
These genes involve up-regulation of surface molecules including
the Fas receptor (TNFRSF6), one of the best-characterized pro-
apoptotic pathways in the liver [25]. Subsequent validation of this
finding, using in situ immunohistochemistry indicated a dramatic
increase in apoptosis in liver of Xpd
TTD mutant mice at both
young and old age, concomitant with activation of p53. The tumor
suppressor p53 is a central component of the stress-activated
pathway that controls cell fate after DNA damage, leading to a
transient arrest of the cell cycle, a permanent senescent-like arrest
or apoptosis [26]. p53 is normally present in a latent form at low
levels, but upon DNA damage p53 accumulates and is activated.
With respect to aging p53 acts as a double-edged sword [15]. It
suppresses cancer, a major aging-related disease, but contributes to
other, non-cancer, degenerative aging phenotypes through
depletion of cells, including stem cells. Indeed, constitutively
activated p53 is considered to be a pro-aging factor, contributing
to premature aging phenotypes displayed in mouse models with
defects in genome maintenance [27]. Moreover, p53 is a potent
suppressor of IGF-1 signaling at multiple points [28], which may
in part explain reduced IGF1 signaling observed in the Xpd
TTD
mice (see below).
High levels of apoptosis in an organ with a regenerative capacity
such as the liver would protect against cancer, but possibly at the
cost of functional decline [15]. For the organism to survive, lost
cells must be replaced and the balance between cell loss and cell
renewal ultimately determines organ functional capacity. When
loss exceeds replacement, it will lead to a decline in organ function
and ultimately organ failure. Therefore, adult mammals require
extensive proliferation and tissue replacement to survive over
longer periods of time. Our observation of an up-regulation of
genes related to cell growth and cell signaling may represent a
compensatory adjustment for the cell loss by apoptosis (Figure 1C).
Indeed, one of the up-regulated genes in this cluster, Signal
transducer and activator of transcription-3 (STAT3), is known to
play a critical role in liver regeneration and protect liver against
Fas-mediated apoptosis [29] [30]. These findings suggest that the
increased cell loss through apoptosis is balanced by regeneration
mediated through the STAT3 signaling pathway. We confirmed
the increase in cell proliferation by Ki-67 immunostaining
(Figure 2). However, Ki-67 positive cells were outnumbered by
TUNEL positive cells even at young age, suggesting that there is a
homeostatic imbalance towards eventual cell loss.
It is possible that the increased apoptosis underlies some of the
phenotypes observed in the Xpd
TTD mouse, most notably the
reduced incidence of cancer [11]. The latter is in keeping with the
lack of excess genomic instability in the Xpd mutant mice [31],
which is in striking contrast to the situation in Xpa null mice in
which an accelerated mutation accumulation has already been
observed before 10 months [32]. Taken together these results
suggest that the tumor suppression facilitated by a strong increase
in the apoptotic response outweighs the contribution of a repair
defect to genomic instability in the Xpd
TTD mice and comes at a
cost of excessive cell loss.
Major metabolic changes in the liver of Xpd
TTD mice
Our results indicate that metabolic pathways central to fatty
acid and cholesterol homeostasis are significantly altered in
Xpd
TTD liver, both at young and old age (Figure 1). The pathway
analysis pointed towards PPARa, as a major regulator responsible
for the coordinated down-regulation of genes involved in lipid
metabolism in the Xpd
TTD mutant liver (Figure 1C). Recent in
vitro evidence showing a novel Xpd
TTD-associated defect in
transcription due to decreased TFIIH-mediated phosphorylation
of nuclear receptor transactivators, including PPARs, vitamin D
receptor (VDR), and retinoic acid receptor (RAR) [9] [33] [34],
may provide the mechanistic explanation for concerted down-
regulation of PPARa and its target genes involved in lipid
metabolism in the Xpd
TTD liver. PPARa also regulates detoxifying
enzyme-encoding genes. Accordingly, in the Xpd
TTD liver, we
observed a dramatic down-regulation of genes involved in
xenobiotic metabolism (Table S5). Detoxification and elimination
of xenobiotics and endobiotics is a major function of liver and is
important in maintaining metabolic homeostasis of the organism
[35]. The down-regulation of genes involved in xenobiotic
metabolism may represent a decrease in the ability of these mice
to neutralize both exogenous toxic compounds and endogenous
deleterious byproducts of metabolism. Inefficient activity of this
system is consistent with age-pigment (lipofuscin) accumulation
observed in the liver of the Xpd
TTD mutant [11]. The down-
regulation of gene involved in lipid metabolism especially lipid
biosynthesis may be responsible for the reduction of growth, body
weight and liver weight observed in the Xpd mutant mice [11].
Down-regulation of IGF-1 signaling in the liver of Xpd
TTD
mice
Microarray analysis and direct examination of the serum levels
of IGF-1, IGFBP-1 and IGFBP-3 confirmed the reduced activity
of the IGF-1 axis in the Xpd
TTD mutant mice, at both young and
old age (Figure 1C and Figure 3). Attenuation of IGF-1 signaling,
as observed in the Xpd
TTD mice, may represent a general,
hormonal response to increased stress including genotoxic stress
[36] [37]. This is in keeping with recent results [38] [39] [40],
indicating reduced IGF-1 serum levels in mice harboring a DNA
repair defect and showing symptoms of accelerated aging. IGF-1
inhibits apoptosis and promotes proliferation. The significant
down-regulation of IGF-1 may underlie the increasing imbalance
between cell loss and renewal in the Xpd
TTD mice with age.
Moreover, such a response is likely to involve the observed
alterations in energy metabolism as an attempt to reduce the
generation of reactive oxygen species (ROS) to limit the onslaught
of spontaneous DNA damage [36,38]. Indeed, the characteristics
of the observed expression profiles in the liver of Xpd
TTD mice are
consistent with reduced energy production through down-
regulation of genes involved in lipid metabolism, lipid mobiliza-
tion, TCA cycle, oxidative phosphorylation, and electron transport
(Figure 1C). Moreover, upregulation of genes involved in eliciting
a fasting response is a molecular signature in the Xpd
TTD mutant
liver, possibly as a response to energy starvation due to reduced
energy production (Table S5).
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the Xpd
TTD liver are consistent with increased cellular and
metabolic responses to genotoxic stress, which can explain most, if
not all, of the premature aging phenotypes in this mutant mouse
model (Figure 4). For example, increased apoptosis could explain the
atrophy, sarcopenia, cachexia, osteoporosis, kyphosis, and lymphoid
depletion as well as the reduced incidence of cancer observed in
Xpd
TTD mice [11]. The metabolic alterations together with the
observed down-regulation of IGF-1 signaling would reduce DNA
damage and explains the phenotypes observed in these animals that
are reminiscent of caloric restriction (CR) [11]. Notably, Xpd
TTD
livers at 20 month show down-regulation of genes in the functional
categories of immune response as compared to their age-matched
controls (Figure 1). It is possible that this reflects the severe depletion
of cells in spleen and thymus observed in the Xpd
TTD mice [11],
which is likely also caused byincreased apoptosis and reduced IGF-1
action [38]. The data presented here support the hypothesis that the
homeostatic imbalance between cell loss and cell renewal underlies
premature aging in the Xpd
TTD mice through a complex interplay
between cellularresponses and compensatory metabolic adjustments
toincreasedgenotoxicstress.Thesecompensatoryadjustmentscould
be exploited in developing novel interventions that may attenuate
some of the adverse effects of aging in humans. Short-lived,
progeroid mouse models due to defects in genome maintenance
are ideal tools for that purpose.
Materials and Methods
Mouse liver samples
Liver samples were obtained from longevity cohorts of
homozygous mutant Xpd
TTD mice and C57BL/6 controls [11].
Xpd
TTD mice used in this study carry a R722W mutation at the
mouse XPD gene. Generation of Xpd
TTD mice by targeting of the
Xpd
R722W allele has been described previously [41]. To obtain a
genetically homogenous background, Xpd
TTD mice were back-
crossed over 10 times into a C57BL/6 background. Liver samples
of intact animals were dissected for histopathology and preserved
in a neutral aqueous phosphate-buffered 4% solution of
formaldehyde (10% neutral buffered formalin). Tissues required
for microscopic examination were embedded in paraffin wax,
sectioned at 5 mm and stained with haematoxylin and eosin. Part
of each sample was snap-frozen in liquid nitrogen for microarray
analyses. We abided by guidelines of National Institute of Public
Health and the Environment (Bilthoven, the Netherlands) on
animal husbandry and experiments.
Extraction of RNA from tissues and cDNA labeling
Frozen liver samples were weighed (0.05–0.075 gram), cut into
small pieces on dry ice, and then placed in 1 ml of TRIZOL
Reagent (Invitrogen, Carsbad, CA, USA) per 50–100 mg of tissue.
The total RNA was isolated according to the TRIZOL Reagent
protocol and further purified using the Qiagen RNeasy (Qiagen,
Valencia CA, USA) purification kit in accordance with the
manufacturer’s protocols. Quality of RNA was assessed using the
Agilent 2100 Bioanalyzer lab-on-a-chip system (Agilent Technol-
ogies, Palo Alto, CA, USA). Nine mg of total RNA was reverse
transcribed to cDNA with oligo-dT as the primer and the
aminoallyl-modified cDNA was chemically coupled to Cy3 and
Cy5 N-hydroxysuccimidyl esters (Amersham Biosciences, USA)
according to BD Atlas PowerScript Fluorescence labeling protocol
(San Jose, CA, USA).
Long oligonucleotide microarray fabrication,
hybridization and image analysis
Microarrays were manufactured in-house using the long
oligonucleotide (70-mer) of the Mouse Genome Oligo Set Version
2 (Operon) which contains the 16,463 unique genes designed from
Figure 4. Schematic depiction of hypothetical pathways leading to the premature aging-phenotypes observed in the livers of
Xpd
TTD mice. Pathological phenotypes are indicated in the blue box, whereas molecular phenotypes detected by tissue and microarray array
analysis are indicated with upward arrows for upregulation, and downward arrows for downregulation. Hypothetical links are indicated in broken
lines. See text for details.
doi:10.1371/journal.pone.0002346.g004
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(February 2002) and the mouse Reference sequence (RefSeq)
Database. Description of the oligonucleotide set is provided by
Operon as follows. More than 98% of the oligonucleotides were
within 1000 bases from the 39-end of the available sequence.
Oligonucleotides were selected to limit secondary structure and
designed to have melting temperature of 7865uC. An amino
linker was attached to the 59-end of each oligonucleotide. BLAST
alignments were performed to exclude oligonucleotides that could
cross-hybridize with other sequences of the Mouse UniGene
Database. Each oligonucleotide had #70% of overall identity to
any other gene and could not have .20 contiguous bases common
to any other gene. The set also included randomized oligonucle-
otides and bacterial sequences as negative control and multiple
sequenced of sets of house-keeping genes as positive control.
Oligonucleotides were spotted on Corning UltraGAPS slides in
36 SSC buffer, using a GeneMachines OmniGrid (Genomic
Solutions, MI, USA) microarray printer, and a Qiagen BioRobot
3000 liquid handler (LabX, ON, Canada) to manage oligonucle-
otide libraries (Operon Biotechnologies, AL, USA). For each
experimental sample, Cy3-labeled mutant sample and Cy5-labled
wild type sample were co-hybridized to a spotted microarray. In
each comparison, dye was swapped and co-hybridized to another
microarray. Hybridization was conducted in Lucidea SlidePro
(Amersham Biosciences, CA, USA) automated hybridization
station. Following hybridization, microarrays was imaged using
an Axon GenePix 4000 microarray scanner (Axon Instrument,
CA, USA). Image analysis was carried out using the software Spot,
a software package for the analysis of microarray images to extract
spot intensity data from 16-bit tiff image files. Quality measure-
ment of arrays was carried out using Marray, a package for
diagnostic plots and normalization of microarray data in
Bioconductor (www.bioconductor.org), to assess quality.
Microarray data analysis
Linear Models for Microarray Data Package (Limma, Biocon-
ductor) was used for data analysis. Within Limma, minimum
background correction and print-tip loess normalization was
performed for each array to remove intensity-dependent dye bias
and spatial effect. Differential expression of genes was determined
using an empirical Bayes (EB) approach within Limma. Fold
difference was calculated from the estimated log ratio. We
computed moderated t-statistics, log-odds ratios of differential
expression (based on empirical Bayes shrinkage of the standard
errors towards a common value), and adjusted p-values (obtained
using the Bonferroni correction) using functions in the limma
library of the Bioconductor software package. After EB analysis
within Limma, genes was ranked as being differentially expressed
in decreasing order of the B-statistic (essentially the log-odds of
differential expression) and cut-off for significance was determined
through volcano plots. To identify functional pathways that
significantly alter Gene Ontology (GO) annotations was assigned
using GoMiner. This tool identifies GO categories of genes that
are significantly over-represented relative to overall proportion of
all altered genes to the total number of genes on microarray, using
two-tailed Fisher’s exact test. Since a particular protein may
function in several processes, may contain domains that carry out
diverse molecular functions, and may be active in multiple
locations in the cell, single genes were redundantly associated
with multiple GO categories. Since Gominer does not take
multiple testing into consideration, we also used three other
software applications for GO annotation, Gostat, GoToolBox, and
EASE, to identify the GO categories that stay over-represented
after multiple testing. Complex phenotypes are controlled by the
dynamic actions of thousands of genes. While GO offers
tremendous value, it also has limitations, such as the lack of direct
association with pathways. Global organization of genes into
pathways and their interactions can be identified through
construction of genomic networks. To analyze functional pathways
that are coordinately regulated, the gene list generated by
microarray analysis was analyzed using PathwayAssist software
(Ariadne Genomics, Rockville, MD, USA), which is a software tool
to generate biological association network. It allows for the
identification and visualization of pathways, gene regulation
networks and protein interaction maps. The software program
utilizes a natural language processor to extract information from
databases such as Pub Med to provide direct associations and
graphically identify all known relationships between the differen-
tially expressed genes.
Microarray experimental design
To identify the biochemical and metabolic pathways that are
altered in the liver of Xpd
TTD mutant, we compared the gene
expression profiles between Xpd
TTD mutant and wild type. Our
experimental design involved direct pair-wise comparison between
mutant and wild type at young age (3 months, 5 individuals per
group) including a dye swap comparison (a total of 10 slides). For
old age (20 months) we had 3 individuals available per group.
Since this reduced number of animals would lead to a loss of
power, both due to animal-to-animal variation and a smaller
number of replicates, to compensate for the latter, we compared
all possible combinations between mutant and wild type animals,
including dye swap experiments (a total of 18 slides). Agreement
among the technical replicates was high, with correlation
coefficient r
2=0.88. The statistical cut off at old young age was
p,0.01 when adjusted for multiple testing (B.0), while at old age
the cut off was much more stringent (p,1E-7, B.10) as we had 6
technical duplicates in each sample as compared to 2 technical
duplicates at young age, artificially lowering the standard error.
Real-time quantitative PCR
The ABI Prism 7900HT system was used for amplification and
data collection. All reactions were run using a ready to use primer
and probe set predesigned by Applied Biosystems (Assay-on
demand Gene Expression Product). Reactions were carried out in
a total volume of 10 ml. Each reaction contained 5 mlo f2 6
Master Mix, 800 nM of each primer, dH2O, and 2 ml of cDNA
template. A pre-incubation step of 10 min at 95uC to activate the
AmpliTaq DNA GoldH
DNA polymerase was followed by 40
amplification cycles. Each cycle consisted of a 15 s denaturation
step at 95uC and an annealing/extension step for 1 min at 60uC.
A disassociation step to detect non-specific amplification was
added to the end of the run. The PCR raw data was analyzed
using Applied Biosystems SDS v2.0 software. We tested samples
from the five mutant and five wild type control mice at young
(13 weeks) age and three mutant and three wild type control mice
at old age (20 months). The CT value for each biological replicate
represents the average of three technical replicates. The relative
amounts of specifically amplified cDNAs were calculated with the
comparative threshold cycle (DDCT) method. Beta-actin was used
as a normalizer.
Tissue arrays and immunohistochemistry
Livers were removed, formalin-fixed, paraffin-embedded, and
sectioned. For tissue array construction, a H&E-stained tissue
section was made from each donor block to define representative
regions. Two core tissue biopsies were taken from individual
paraffin-embedded liver samples (donor blocks) and arranged in a
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apparatus (Superbiochips Laboratories, Seoul, Korea). Each tissue
array block contained up to 60 samples. Sections of 4 mm were cut
from each tissue array block, deparaffinized and dehydrated.
Immunohistochemical detection of apoptosis was carried out using
an In Situ Cell Death Detection Kit (Boehringer Mannheim)
following the procedures provided by the manufacturer as
described before [42]. Briefly, paraffin-embedded tissue sections
were dewaxed and rehydrated according to standard protocols
[43] and then treated with proteinase K (20 mg/ml in 10 mM Tris
pH 7.4) for 15 min at 30uC. After rinsing the slides with
phosphate buffered saline (PBS), the sections were incubated with
a blocking solution (0.3% H2O2 in methanol) for 1 hr at room
temperature. After rinsing with PBS, the sections were incubated
in a permeabilization solution (0.1% Triton X-100 in 0.1%
sodium citrate) for 2 min at 4uC. After rinsing twice with PBS, the
sections were incubated with 50 ml TUNEL reaction mixture for
1h ra t3 7 uC, 50 ml Converter-POD for 30 min at 37uC, and
100 ml DAB-substrate solution for 2 min at room temperature,
where the sections were rinsed three times with PBS between each
step. The slide was analyzed under a light microscope. The
number of apoptotic cells was scored from pictures of six images
made from two core biopsies from an individual animal with three
animals per age group per genotype, and average numbers of
apoptotic cells from two different slides were plotted against time
genotype and age. Immunohistochemical staining against p53
[1:100; IC12, #2524 (Cell Signaling Technology, USA)] and
Caspase-3 [1:100; #9661 (Cell Signaling Technology)] was
performed using a streptavidin peroxidase procedure. After
deparaffinization and rehydration, tissue sections were treated three
times with microwaves in 0.01 M citrate buffer (pH 6.0) for 5 min
each time. The sections were then immersed in methanol containing
0.3% hydrogen peroxidase for 6 min to block the endogenous
peroxidase activity, and incubated in 2.5% blocking serum to reduce
non-specific binding. After incubation with primary antibodies, the
sectionswereincubatedwithbiotinylated anti-rabbitIgGandavitin–
biotin peroxidase (Vector Laboratories, Burlingame, CA), and
visualized using diaminobenzidine tetrahydrochloride. Two anti-
bodies among various commercially available antibodies were
selected after the test procedure using a human control slide for
immunohistochemistry (Superbiochips Laboratories). Statistical
analysis was performed in SAS (version 9.01) using the Npar1 way
procedure. The Wilcoxon Mann-Whitney test with the EXACT p-
value option was utilized for significance test.
ELISAs for Mouse IGF-1, IGFBP-1, and -3
The levels of murine IGF-1, IGFBP-1, and IGFBP-3 were
measured using in-house enzyme-linked immunoassays. Mouse
recombinant IGF-1, IGFBP-1, and IGFBP-3 protein standards,
monoclonal antibodies and biotinylated polyclonal antibodies were
purchased from R&D systems (Minneapolis, MN). Microtiter
plates were obtained from Nalge Nunc International (Rochester,
NY). Streptavidin-HRP conjugate, o-phenylenediamine dihydro-
chloride (OPD) and hydrogen peroxide substrate were purchased
from Pierce (Rockford, IL). Ninety-six well microtiter plates were
coated with capture antibody at pH 7.4, incubated overnight at
room temperature on a shaker, then washed 3 times with PBS/
Tween-20 followed by incubation with blocking buffer and 3 final
washes. Recombinant mouse protein standards were diluted in
sample buffer in concentrations ranging from 0 to 250 ng/ml. For
IGF-1 assay, the serum samples were pre-extracted with acid/
ethanol reagent (12.5% 2N HCl and 87.5% ethanol), neutralized
with 1M Tris base and diluted with assay buffer. For IGFBP
assays, serum samples were pre-diluted 10–400-fold prior to assay.
Standards, controls or diluted samples were incubated at room
temperature for 2 hour on shaker. The wells were washed 3 times
with wash buffer followed by the addition of detection antibody
and incubated at room temperature for 2 hours. The wells were
then washed 3 times and streptavidin-HRP conjugate was added
and further incubated for 20 min at room temperature. After 4
washes, 100 ml of OPD (1 mg/ml in hydrogen peroxide substrate)
was added to each well and incubated for additional 10 min. The
reaction was stopped by the addition of 50 mlo f2 NH 2SO4 and
the absorbance was determined at 490 nm in a plate reader
(Molecular Design, Sunnyvale, CA). The standard curve was
analyzed using 4-parameter logistic curve-fit. The IGF-1 assay has
a sensitivity of 0.1 ng/ml. The intra-assay and inter-assay coefficient
ofvariationswere,10%intherangefrom1to10 ng/ml.IGFBP-1,
and IGFBP-3 assays have a sensitivity of 0.2 ng/ml. The intra-assay
and inter-assay coefficient of variations were ,6% and ,8%,
respectively, in the range from 1 to 6 ng/ml.
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